# A Duloxetine Dosing Strategy Study in Korean Patients With Major Depressive Disorder

> **NCT00960986** · PHASE4 · COMPLETED · sponsor: **Eli Lilly and Company** · enrollment: 249 (actual)

## Conditions studied

- Major Depressive Disorder (MDD)

## Interventions

- **DRUG:** Duloxetine hydrochloride

## Key facts

- **NCT ID:** NCT00960986
- **Lead sponsor:** Eli Lilly and Company
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-08
- **Primary completion:** 2011-02
- **Final completion:** 2011-04
- **Target enrollment:** 249 (ACTUAL)
- **Last updated:** 2014-12-31

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00960986

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00960986, "A Duloxetine Dosing Strategy Study in Korean Patients With Major Depressive Disorder". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00960986. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*